KR20030019587A - 바이러스 감염의 치료에 있어서 il-8 수용체 길항제의용도 - Google Patents
바이러스 감염의 치료에 있어서 il-8 수용체 길항제의용도 Download PDFInfo
- Publication number
- KR20030019587A KR20030019587A KR10-2003-7000717A KR20037000717A KR20030019587A KR 20030019587 A KR20030019587 A KR 20030019587A KR 20037000717 A KR20037000717 A KR 20037000717A KR 20030019587 A KR20030019587 A KR 20030019587A
- Authority
- KR
- South Korea
- Prior art keywords
- respiratory
- viral infection
- therapeutic agent
- human
- infection
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21905300P | 2000-07-18 | 2000-07-18 | |
US60/219,053 | 2000-07-18 | ||
PCT/US2001/022328 WO2002005814A1 (en) | 2000-07-18 | 2001-07-16 | Use of il-8 receptor antagonists in the treatment of virus infections |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20030019587A true KR20030019587A (ko) | 2003-03-06 |
Family
ID=22817645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2003-7000717A KR20030019587A (ko) | 2000-07-18 | 2001-07-16 | 바이러스 감염의 치료에 있어서 il-8 수용체 길항제의용도 |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1307190A4 (ja) |
JP (1) | JP2004509852A (ja) |
KR (1) | KR20030019587A (ja) |
CN (1) | CN1449285A (ja) |
AR (1) | AR033830A1 (ja) |
AU (1) | AU2001273497A1 (ja) |
BR (1) | BR0112603A (ja) |
CA (1) | CA2418162A1 (ja) |
CZ (1) | CZ2003132A3 (ja) |
HU (1) | HUP0300754A3 (ja) |
IL (1) | IL153921A0 (ja) |
MX (1) | MXPA03000500A (ja) |
NO (1) | NO20030201L (ja) |
NZ (1) | NZ523659A (ja) |
PL (1) | PL365886A1 (ja) |
WO (1) | WO2002005814A1 (ja) |
ZA (1) | ZA200300474B (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2007001561A (es) * | 2004-08-04 | 2007-04-16 | Schering Corp | Formulacion farmaceutica que comprende pleconaril para tratamiento de enfermedades de vias aereas. |
CN107072976A (zh) * | 2014-05-12 | 2017-08-18 | 葛兰素史克知识产权第二有限公司 | 用于治疗传染性疾病的包含Danirixin的药物组合物 |
EP4008325A1 (en) * | 2020-12-02 | 2022-06-08 | Dompe' Farmaceutici S.P.A. | Cxcl8 inhibitors for use in the treatment of covid-19 |
WO2021191305A1 (en) * | 2020-03-26 | 2021-09-30 | Dompe' Farmaceutici Spa | Cxcl8 inhibitors for use in the treatment of covid-19 |
EP3884932A1 (en) * | 2020-03-26 | 2021-09-29 | Dompe' Farmaceutici S.P.A. | Cxcl8 inhibitors for use in the treatment of covid-19 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5547979A (en) * | 1992-03-30 | 1996-08-20 | Smithkline Beecham | TNF inhibition |
AU3539795A (en) * | 1994-08-25 | 1996-03-14 | Medical University Of South Carolina | Methods of treating cold symptoms using pentoxifylline |
JPH11503110A (ja) * | 1995-02-17 | 1999-03-23 | スミスクライン・ビーチャム・コーポレイション | Il−8受容体拮抗剤 |
SE9802729D0 (sv) * | 1998-08-13 | 1998-08-13 | Astra Pharma Prod | Novel Compounds |
SE9802937D0 (sv) * | 1998-09-01 | 1998-09-01 | Astra Pharma Prod | Novel compounds |
-
2001
- 2001-07-16 AU AU2001273497A patent/AU2001273497A1/en not_active Abandoned
- 2001-07-16 HU HU0300754A patent/HUP0300754A3/hu unknown
- 2001-07-16 MX MXPA03000500A patent/MXPA03000500A/es unknown
- 2001-07-16 WO PCT/US2001/022328 patent/WO2002005814A1/en active Application Filing
- 2001-07-16 CA CA002418162A patent/CA2418162A1/en not_active Abandoned
- 2001-07-16 NZ NZ523659A patent/NZ523659A/en unknown
- 2001-07-16 CN CN01813095A patent/CN1449285A/zh active Pending
- 2001-07-16 JP JP2002511746A patent/JP2004509852A/ja not_active Withdrawn
- 2001-07-16 IL IL15392101A patent/IL153921A0/xx unknown
- 2001-07-16 EP EP01952777A patent/EP1307190A4/en not_active Withdrawn
- 2001-07-16 PL PL01365886A patent/PL365886A1/xx not_active Application Discontinuation
- 2001-07-16 BR BR0112603-2A patent/BR0112603A/pt not_active IP Right Cessation
- 2001-07-16 AR ARP010103395A patent/AR033830A1/es not_active Application Discontinuation
- 2001-07-16 CZ CZ2003132A patent/CZ2003132A3/cs unknown
- 2001-07-16 KR KR10-2003-7000717A patent/KR20030019587A/ko not_active Application Discontinuation
-
2003
- 2003-01-15 NO NO20030201A patent/NO20030201L/no not_active Application Discontinuation
- 2003-01-17 ZA ZA200300474A patent/ZA200300474B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CZ2003132A3 (cs) | 2003-09-17 |
CN1449285A (zh) | 2003-10-15 |
EP1307190A1 (en) | 2003-05-07 |
CA2418162A1 (en) | 2002-01-24 |
HUP0300754A3 (en) | 2009-03-02 |
BR0112603A (pt) | 2004-08-24 |
JP2004509852A (ja) | 2004-04-02 |
AR033830A1 (es) | 2004-01-07 |
NZ523659A (en) | 2006-01-27 |
NO20030201D0 (no) | 2003-01-15 |
WO2002005814A1 (en) | 2002-01-24 |
EP1307190A4 (en) | 2007-08-22 |
AU2001273497A1 (en) | 2002-01-30 |
HUP0300754A2 (hu) | 2003-08-28 |
ZA200300474B (en) | 2004-08-17 |
PL365886A1 (en) | 2005-01-10 |
IL153921A0 (en) | 2003-07-31 |
NO20030201L (no) | 2003-03-17 |
MXPA03000500A (es) | 2003-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU716821B2 (en) | Method to improve the biological and antiviral activity of protease inhibitors | |
Mehla et al. | Programming of neurotoxic cofactor CXCL-10 in HIV-1-associated dementia: abrogation of CXCL-10-induced neuro-glial toxicity in vitro by PKC activator | |
KR20040084913A (ko) | 염증 및 aids-관련된 신경계 장애의 치료 방법 및조성물 | |
JP3306830B2 (ja) | レトロウイルスインテグラーゼの阻害剤 | |
US6894021B2 (en) | Method for identifying and using A2B adenosine receptor antagonists to mediate mammalian cell proliferation | |
Yoon et al. | Rhinovirus regulation of IL-1 receptor antagonist in vivo and in vitro: a potential mechanism of symptom resolution | |
WO2021214299A1 (en) | Nicotinamide mononucleotide and nicotinamide riboside derivatives and use thereof in the treatment of viral infections and respiratory complications, in particular caused by influenzavirus or coronavirus | |
Bergamini et al. | Macrophage colony-stimulating factor enhances the susceptibility of macrophages to infection by human immunodeficiency virus and reduces the activity of compounds that inhibit virus binding | |
KR20030019587A (ko) | 바이러스 감염의 치료에 있어서 il-8 수용체 길항제의용도 | |
US20040038854A1 (en) | Use of il-8 receptor antagonists in the treatment of virus infections | |
Song et al. | Human interleukin‐6 induces human herpesvirus‐8 replication in a body cavity‐based lymphoma cell line | |
US20040022762A1 (en) | Use of il-8 protein modulators in the treatment of viral infections | |
JP2004083576A (ja) | Hiv感受性株に対して活性をもち、ヌクレオシド系ならびに非ヌクレオシド系の逆転写酵素阻害剤、およびプロテアーゼ阻害剤に対し抵抗性のhiv株に対して活性をもつ抗レトロウイルス治療薬を得るための、クロロキン、ヒドロキシクロロキン、および4アミノ−キノリン酸誘導体の使用 | |
TW200418812A (en) | IL-8 receptor antagonists | |
Benelli et al. | Distinct chemotactic and angiogenic activities of peptides derived from Kaposi's sarcoma virus encoded chemokines. | |
EP0425109B1 (en) | 3-Substituted-2-oxindole derivatives as inhibitors of interleukin-1 biosynthesis | |
JP7069120B2 (ja) | エボラ(ebola)及びマールブルク(marburg)病を治療するためのtlr4拮抗薬としてのエリトランの使用方法 | |
Pedersen et al. | Effects of Chloroquine, Mefloquine and Quinine on Natural Killer Cell Activity in vitro: An Analysis of the Inhibitory Mechanism | |
WO2006041838A2 (en) | Heparinoid compositions for treatment and prevention of dementia | |
Kalovidouris | Dysfunction of the sarcoplasmic reticulum in polymyositis | |
CA2142831A1 (en) | Treatment of human viral infections | |
KR101875997B1 (ko) | 엔-메탄노카르바티미딘을 이용한 대상포진의 치료방법 | |
US20130035357A1 (en) | Compositions and Methods for Preventing Joint Destruction in Osteoarthritis | |
US8067430B1 (en) | Anti-HIV activity of the opioid antagonist naloxone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |